科赫勒斯生物科學CHRS
那斯達克 · USD
1.43
+0.10
(+7.52%)
收盤 12/12 04:59 (UTC+8)
盤後
1.44
+0.01
(+0.70%)
12/12 04:59 (UTC+8)
科赫勒斯生物科學CHRS
1.43
+0.10
(+7.52%)
財務數據
損益表
- 0.59
- 0.75
- 0.92
- 0.77
- 1.40
- 0.71
- 2.48
- 0.08
- 0.10
- 0.12
- 81.02
- 27.00
- 22.74
- -15.80
- 81.32
- -49.35
- 250.84
- -85.97
- 34.94
- 12.84
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 11,571 | 10,254 | 7,599 | 248,304 | 70,774 | 139,734 | 77,063 | 91,524 | 74,568 | 58,716 |
營業成本 | 3,721 | 3,395 | 2,653 | 111,576 | 20,741 | 61,515 | 34,586 | 84,567 | 32,703 | 24,848 |
營業毛利 | 7,850 | 6,859 | 4,946 | 136,728 | 50,033 | 78,219 | 42,477 | 6,957 | 41,865 | 33,868 |
營業費用 | 52,183 | 52,345 | - | 94,126 | 56,420 | - | - | - | 73,871 | 68,411 |
研發費用 | 27,252 | 26,306 | 24,356 | 22,262 | 21,676 | 22,001 | 28,470 | 26,368 | 25,647 | 23,267 |
推銷及管理費用 | 24,931 | 26,039 | 26,025 | 71,864 | 34,744 | 51,465 | 56,532 | 49,494 | 48,224 | 45,144 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -44,333 | -45,486 | -45,435 | 42,602 | -6,387 | 4,753 | -42,525 | -68,905 | -32,006 | -34,543 |
其他收入及費用 | 2,141 | 2,901 | 187 | 173,542 | 998 | 166,569 | 156,516 | -129 | 2,253 | 1,617 |
利息費用 | 2,325 | 2,277 | 2,150 | 18,336 | 5,362 | 13,332 | 11,116 | 10,619 | 10,268 | 9,943 |
稅前純益 | -44,517 | -44,862 | -47,398 | 197,808 | -10,751 | 157,990 | 102,875 | -79,653 | -40,021 | -42,869 |
所得稅 | - | - | - | - | - | - | - | - | -380 | - |
稅後純益 | -35,531 | 297,767 | -56,569 | -50,696 | -10,751 | -12,921 | 102,875 | -79,653 | -39,641 | -42,869 |
基本每股稅後盈餘(元) | -0.31 | 2.57 | -0.49 | -0.44 | -0.09 | -0.11 | 0.91 | -0.71 | -0.41 | -0.49 |
稀釋每股稅後盈餘(元) | -0.31 | 2.57 | -0.49 | -0.44 | -0.10 | -0.12 | 0.91 | -0.74 | -0.37 | -0.46 |
基本平均股數(千股) | 116229.00 | 116077.00 | 115857.00 | 115418.00 | 115210.00 | 114819.00 | 112749.00 | 111492.00 | 97738.00 | 87269.00 |
稀釋平均股數(千股) | 116229.00 | 116077.00 | 115857.00 | 115418.00 | 115210.00 | 114819.00 | 112749.00 | 111492.00 | 97738.00 | 87269.00 |
還原基本每股稅後盈餘(元) | -0.31 | 2.57 | -0.49 | -0.44 | -0.09 | -0.11 | 0.91 | -0.71 | -0.41 | -0.49 |
還原稀釋每股稅後盈餘(元) | -0.31 | 2.57 | -0.49 | -0.44 | -0.10 | -0.12 | 0.91 | -0.74 | -0.37 | -0.46 |
還原基本平均股數(千股) | 116,229 | 116,077 | 115,857 | 115,418 | 115,210 | 114,819 | 112,749 | 111,492 | 97,738 | 87,269 |
還原稀釋平均股數(千股) | 116,229 | 116,077 | 115,857 | 115,418 | 115,210 | 114,819 | 112,749 | 111,492 | 97,738 | 87,269 |
EBITDA(千元) | -32,240 | 301,060 | -53,373 | -27,168 | -3,840 | 1,598 | 115,498 | -71,023 | -31,689 | -34,280 |